Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours

Fig. 4

Expression of (a) phosphorylated XPA and (b) its increase after CDDP treatment in CDDP-resistant (H12.1ODM, 1411HP and 1777NRpmet) and -sensitive (H12.1) GCT cell lines. CDDP-treated samples are shown in hatched columns. Upper panel shows representative dot blot. Lower panels (graphs) are quantitative analyses of three technical replicates of three biological replicates with error bars representing the standard deviation. * p ≤ 0.01, ** p ≤ 0.005, *** p ≤ 0.001

Back to article page